New hope for heart lining pain: can CardiolRx keep flare-ups away?
NCT ID NCT06708299
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This study tests whether the drug CardiolRx can prevent another episode of pericarditis (inflammation around the heart) in people who have had repeated attacks. About 110 adults who have been stable on an IL-1 blocker for at least a year will stop that medication and receive either CardiolRx or a placebo for 24 weeks. The goal is to see if CardiolRx helps them stay free of recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT PERICARDITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Altman Clinical and Translational Research Institute
RECRUITINGLa Jolla, California, 92037, United States
-
Cedars-Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Columbia University - New York Presbyterian
RECRUITINGNew York, New York, 10032, United States
-
Fatebenefratelli Hospital Milano
NOT_YET_RECRUITINGMilan, Italy
-
Hippokration General Hospital
RECRUITINGAthens, Greece
-
Houston Methodist Hospital
RECRUITINGHouston, Texas, 77030, United States
-
Jewish General Hospital
RECRUITINGMontreal, Canada
-
Johns Hopkins University
RECRUITINGBaltimore, Maryland, 21205, United States
-
Lenox Hill Hospital
RECRUITINGNew York, New York, 11030, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
-
Mayo Clinic Florida
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Clionic Arizona
RECRUITINGPhoenix, Arizona, 85054, United States
-
MedStar Health Institute
RECRUITINGColumbia, Maryland, 21044, United States
-
Minneapolis Heart Institute
RECRUITINGMinneapolis, Minnesota, 55407, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
Northwestern University
RECRUITINGChicago, Illinois, 60208, United States
-
Pacific Heart Institute at Cedars-Sinai
RECRUITINGSanta Monica, California, 90404, United States
-
UCI Health
RECRUITINGIrvine, California, 92697, United States
-
University Hospital
NOT_YET_RECRUITINGTorino, Italy
-
University Hospital Udine
NOT_YET_RECRUITINGUdine, Italy
-
University of Padua
NOT_YET_RECRUITINGPadua, Italy
-
University of Utah Hospital
RECRUITINGSalt Lake City, Utah, 84112, United States
-
University of Vermont
RECRUITINGBurlington, Vermont, 05401, United States
-
University of Virginia
RECRUITINGCharlottesville, Virginia, 22903, United States
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23219, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 500 patients join study to unravel recurrent heart inflammation
- New study aims to predict which patients will get pericarditis again
- New shot aims to keep pericarditis Flare-Ups at bay
- CBD drug shows promise for stubborn heart pain
- New shot aims to stop repeat heart sac inflammation
- New hope for heart inflammation sufferers: experimental drug VTX2735 enters Mid-Stage trial